Warrior Met Coal Q2 Results Confirm Blue Creek Ramp, Prompting Guidance Raise

What happened

Warrior Met Coal’s second-quarter results delivered sharply higher earnings and cash generation as the Blue Creek mine contributed a full quarter of low-cost production, prompting management to raise its full-year sales and production outlook. The update directly addresses the operational execution uncertainty that underpinned our previous WAIT rating, demonstrating that the longwall ramp is sustaining its ~1.5Mt quarterly run-rate and working through inventory. However, the earnings call highlights also likely reflected continued pricing headwinds given the challenging seaborne met coal environment, a factor that still caps the realization of volume growth into free cash flow. With the raised guidance and earlier-than-expected cash generation, the risk of a delayed cash flow inflection has materially diminished, but the stock’s move above our prior $95 trim level suggests optimism may already be priced in. The next key watchpoint is quantitative evidence of sustained price realization and inventory draw toward the sub-1.0Mt target to confirm the durability of the turnaround.

Implication

The Q2 earnings beat and raised guidance validate that Blue Creek’s ramp is on track and that costs are benefiting from the higher volume, substantially de-risking the operational thesis that kept us on WAIT. Cash generation turned positive earlier than guided, reducing the probability of a negative free cash flow first half. While these results are encouraging, the stock has likely already responded, and the valuation may now embed much of this good news. The sustained drag from weak met coal pricing and the need for further inventory reduction to unlock full cash conversion mean the risk-reward is more balanced at current levels. Investors should look for confirmation of improving realizations in subsequent quarters before aggressively adding positions.

Thesis delta

The Q2 performance and raised outlook directly challenge our WAIT rating’s premise that evidence of execution was needed; that evidence has now largely been delivered. With Blue Creek volumes and cost benefits materializing and guidance lifted, the risk of a thesis-breaking miss has receded. However, the investment case now hinges more on the met coal price trajectory, and without a pricing recovery, further upside may be limited, making a shift to BUY contingent on clearer macroeconomic tailwinds.